Proton‐Activated Artificial Channels for pH‐Selective Cancer Therapy
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.202525440 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Daoxin Luo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Innovative Drug Target Research, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine L…. Hauptthemen laut MEDLINE: Protons, Antineoplastic Agents, Ion Channels, Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Program, Fujian Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Proton‐activated ion channels mediate ion transport in response to extracellular acidification, enabling cellular adaptation to acidic microenvironments. Despite their biological importance, mimicking proton‐activated functionality in artificial ion channels remains a significant challenge. Here, we present a novel class of proton‐activated artificial ion channels built from self‐assembled peptide chains integrated into a pH‐responsive 2,2′‐bipyridine scaffold. Protonation induces a conformational switch in the channel‐forming units, promoting one‐dimensional self‐assembly and subsequent hydrophobic packing into functional channels capable of transporting small molecules. As extracellular pH decreases from 7.4 to 6.5, C‐FF exhibits a 10.3‐fold enhancement in cytotoxicity against human colorectal carcinoma cells, boosting an IC 50 of 2.8 µM, mediated through apoptosis induction and cell cycle arrest resulting from disruption of the autophagic process. Significantly, C‐FF demonstrates exceptional selectivity for cancer cells, achieving a selectivity index of 8.5, surpassing that of doxorubicin by one order of magnitude while maintaining comparable potency, highlighting its potential as a pH‐responsive platform for selective anticancer therapy in acidic tumor microenvironments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Innovative Drug Target Research, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, MOE Key Laboratory of Spectrochemical Analysis and Instrume…
- Shenzhen Research Institute of Xiamen University, Shenzhen, Guangdong, China.
- School of Physics, Shandong University, Jinan, Shandong, China.
- School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
ORCID-Profile: Changliang Ren
Förderung
- National Natural Science Foundation of China
- Shenzhen Science and Technology Program
- Fujian Provincial Natural Science Foundation of China
- Scientific Research Foundation of the State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory
- Fundamental Research Funds for the Central Universities
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Luo, D., Jia, C., Lin, Y., Zhou, J., Ren, C., Xie, X., Chen, T., Zeng, Z., Li, W., Mu, Y., & Ren, C. (2026). Proton‐Activated Artificial Channels for pH‐Selective Cancer Therapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202525440
Vancouver
Luo D, Jia C, Lin Y, Zhou J, Ren C, Xie X, et al. Proton‐Activated Artificial Channels for pH‐Selective Cancer Therapy. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.202525440
BibTeX
@article{Luo2026,
author = {Luo, Daoxin and Jia, Chunyan and Lin, Yuchao and Zhou, Jin and Ren, Congrui and Xie, Xiaopan and Chen, Tong and Zeng, Zhiping and Li, Weifeng and Mu, Yuguang and Ren, Changliang},
title = {Proton‐Activated Artificial Channels for pH‐Selective Cancer Therapy},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.202525440}
}
EUVIMED